- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01429480
Comparison of TAP (Transversus Abdominis Plane) and Ilioinguinal/Iliohypogastric Nerve Block for Analgesia of Open Inguinal Herniorrhaphy (TAP)
September 6, 2011 updated by: Hillel Yaffe Medical Center
Comparison Between Two Ultrasound-guided Blocks (Transversus Abdominis Plane and Ilioinguinal/Iliohypogastric Nerve Blocks) for Pain Relief After Open Inguinal Herniorrhaphy
TAP was recommended by PROSPECT for further investigation as an appropriate analgesic method after open herniorrhaphy.
Ilioinguinal/iliohypogastric nerve block is one of the oldest methods of analgesia.
The researchers wish to investigate whether the TAP block is as effective as the ilioinguinal/iliohypogastric nerve block?
Study Overview
Status
Unknown
Conditions
Study Type
Interventional
Enrollment (Anticipated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hadera, Israel, 38100
- Recruiting
- Hillel Yaffe Medical Center
-
Principal Investigator:
- Anatoly Stav, MD
-
Contact:
- Anatoly Stav, MD
- Phone Number: 972-4-630-4529
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Patients undergoing elective primary unilateral open tension-free mesh inguinal hernia repair
Exclusion Criteria:
- Inability to consent to the study
- BMI more than 40
- Skin infection near injection site
- Chronic hepatic or renal failure
- Peripheral neuropathy
- Proven opioid dependency
- Coagulopathy
- Thrombocytopenia
- Dementia
- Lack of orientation
- Impossibility to understand VAS
- Patients suffering from chronic pain
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Group
|
|
|
Active Comparator: TAP Block
|
|
|
Active Comparator: II/IH Block
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
postoperative pain
Time Frame: 2 days postoperatively
|
Intensity of pain in rest and during movement at the operation day and 2 days postoperaive.
|
2 days postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Anticipated)
August 1, 2013
Study Completion (Anticipated)
August 1, 2013
Study Registration Dates
First Submitted
September 4, 2011
First Submitted That Met QC Criteria
September 6, 2011
First Posted (Estimate)
September 7, 2011
Study Record Updates
Last Update Posted (Estimate)
September 7, 2011
Last Update Submitted That Met QC Criteria
September 6, 2011
Last Verified
September 1, 2011
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 0065-11-HYMC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.